• COVID-19 and MS

  Assn. of British Neurologists COVID-19 DMT guidelines

  Posted by ed-tobias on March 12, 2020 at 1:04 pm

  

  The Association of British Neurologists has issued its guidelines regarding the use of disease-modifying treatments during the coronavirus / COVID-19 crisis. The recommendations for each DMT are outlined below, but you can read the full statement here.

  • SAFE TO START OR CONTINUE
    • Avonex, Plegridy, Rebif (interferon beta 1a)
      
    • Aubagio (teriflunomide)
    • Betaseron, Extavia (interferon beta 1b)
    • Copaxone, Glatopa (glatiramer)
  • SAFE, BUT CONSIDER EXTENDING DOSING INTERVAL
    • Tysabri (natalizumab)
  • MODERATELY INCREASED RISK OF BECOMING INFECTED
    • Gilenya (fingolimod)
      
    • Ocrevus (ocrelizumab)
      
  • HIGHER RISK. DON’T START. DELAY ROUND 2.
    • Lemtrada (alemtuzumab)
    • Mavenclad (cladribine)
  • HIGHEST RISK. DON’T START.
    • HSCT

  I suggest you read the full guidelines here.

  Also, please scroll through other, older, posts for guidance from the Italian neurologists association.

   

   

  ed-tobias replied 4 years, 1 month ago 1 Member · 0 Replies

  • coronavirus
  • COVID-19
  • COVID-19 and DMTs
• 0 Replies

Log In to Reply